Bausch Health (BHC)
(Delayed Data from NYSE)
$8.53 USD
+0.17 (2.03%)
Updated Jul 1, 2022 04:00 PM ET
5-Strong Sell of 5 5
A Value C Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for Bausch Health Cos Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 2,119 | 1,816 | 3,244 | 723 | 797 |
Receivables | 1,775 | 1,577 | 1,839 | 1,865 | 2,130 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 993 | 1,094 | 1,107 | 934 | 1,048 |
Other Current Assets | 720 | 855 | 779 | 689 | 771 |
Total Current Assets | 5,607 | 5,342 | 6,969 | 4,211 | 4,746 |
Net Property & Equipment | 1,598 | 1,567 | 1,466 | 1,353 | 1,403 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 2,252 | 2,137 | 1,690 | 1,676 | 433 |
Intangibles | 19,405 | 21,489 | 23,327 | 25,143 | 30,804 |
Deposits & Other Assets | 340 | 664 | 411 | 109 | 111 |
Total Assets | 29,202 | 31,199 | 33,863 | 32,492 | 37,497 |
Liabilities & Shareholders Equity | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 407 | 337 | 503 | 411 | 365 |
Current Portion Long-Term Debt | 0 | 0 | 1,234 | 228 | 209 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 4,791 | 4,576 | 4,511 | 3,197 | 3,694 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 5,198 | 4,913 | 6,248 | 3,836 | 4,268 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 529 | 528 | 705 | 885 | 1,180 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 22,654 | 23,925 | 24,661 | 24,077 | 25,235 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 855 | 1,228 | 1,113 | 879 | 870 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 29,236 | 30,594 | 32,727 | 29,677 | 31,553 |
Shareholders Equity | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 10,317 | 10,227 | 10,172 | 10,121 | 10,090 |
Capital Surplus | 462 | 454 | 429 | 413 | 380 |
Retained Earnings | -8,961 | -8,013 | -7,452 | -5,664 | -2,725 |
Other Equity | -1,852 | -2,063 | -2,013 | -2,055 | -1,801 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -34 | 605 | 1,136 | 2,815 | 5,944 |
Total Liabilities & Shareholder's Equity | 29,202 | 31,199 | 33,863 | 32,492 | 37,497 |
Total Common Equity | -34 | 605 | 1,136 | 2,815 | 5,944 |
Shares Outstanding | 359.40 | 355.40 | 352.50 | 349.70 | 348.50 |
Book Value Per Share | -0.09 | 1.70 | 3.22 | 8.05 | 17.06 |
Fiscal Year End for Bausch Health Cos Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 2,460 | 2,119 | 1,904 | 1,856 | 1,893 |
Receivables | 1,566 | 1,775 | 1,730 | 1,609 | 1,499 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,045 | 993 | 1,058 | 1,086 | 1,076 |
Other Current Assets | 765 | 720 | 632 | 899 | 924 |
Total Current Assets | 5,836 | 5,607 | 5,324 | 5,450 | 5,392 |
Net Property & Equipment | 1,579 | 1,598 | 1,584 | 1,590 | 1,556 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 2,282 | 2,252 | 2,266 | 2,255 | 2,150 |
Intangibles | 19,059 | 19,405 | 19,735 | 20,151 | 20,482 |
Deposits & Other Assets | 334 | 340 | 343 | 596 | 617 |
Total Assets | 29,090 | 29,202 | 29,252 | 30,042 | 30,197 |
Liabilities & Shareholders Equity | 6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 471 | 407 | 455 | 442 | 342 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 4,303 | 4,791 | 4,982 | 5,075 | 4,556 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 4,774 | 5,198 | 5,437 | 5,517 | 4,898 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 552 | 529 | 513 | 516 | 520 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 23,168 | 22,654 | 22,358 | 23,439 | 23,738 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 737 | 1,079 | 1,181 | 1,165 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 29,231 | 29,236 | 29,387 | 30,653 | 30,321 |
Shareholders Equity | 6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 10,373 | 10,317 | 10,312 | 10,300 | 10,289 |
Capital Surplus | 415 | 462 | 437 | 413 | 393 |
Retained Earnings | -9,030 | -8,961 | -9,030 | -9,218 | -8,623 |
Other Equity | -1,899 | -1,852 | -1,854 | -2,106 | -2,183 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -141 | -34 | -135 | -611 | -124 |
Total Liabilities & Shareholder's Equity | 29,090 | 29,202 | 29,252 | 30,042 | 30,197 |
Total Common Equity | -141 | -34 | -135 | -611 | -124 |
Shares Outstanding | 360.90 | 359.40 | 358.80 | 358.80 | 358.40 |
Book Value Per Share | -0.39 | -0.09 | -0.38 | -1.70 | -0.35 |